Evaluation of Cu-PTSM as a tracer of tumor perfusion: Comparison with labeled microspheres in spontaneous canine neoplasms

Carla J. Mathias, Mark Green, Wallace B. Morrison, Deborah W. Knapp

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Copper-62-labeled Cu-PTSM is a promising generator-produced PET tracer for myocardial, cerebral and renal perfusion. To evaluate whether [62Cu]Cu-PTSM could also serve as a blood flow tracer in PET studies of tumor tissue, the tumor uptake of [67Cu]Cu-PTSM was examined in dogs with spontaneously-occurring soft-tissue neoplasms. Copper-67-labeled Cu-PTSM was administered intravenously to four anesthetized dogs, followed c. 5 min later by a left ventricular injection of 85Sr-labeled microspheres (15 μm) to provide an independent measure of tumor perfusion. Forty-seven tumors (average weight = 2.5 ± 3.7 g) were obtained and sectioned into 80 samples. The correlation of 67Cu-PTSM uptake with regional renal perfusion was also examined in data from 395 tissue samples ranging in flow from 0.02 to 9.39 mL min-1 g-1. Rates of tumor perfusion assessed with 85Sr-labeled microspheres ranged from 0.011 to 3.0 mL min-1 g-1. No correlation was found between tumor size and the rate of tumor perfusion. However, an excellent linear correlation exists between tumor perfusion calculated from [67Cu]Cu-PTSM data and tumor perfusion measured with 85Sr-microspheres (r = 0.94 for 80 samples), suggesting that [62Cu]Cu-PTSM may be useful as a radiopharmaceutical for PET studies of tumor perfusion.

Original languageEnglish (US)
Pages (from-to)83-87
Number of pages5
JournalNuclear Medicine and Biology
Volume21
Issue number1
DOIs
StatePublished - 1994
Externally publishedYes

Fingerprint

Microspheres
Canidae
Perfusion
Neoplasms
Copper
Soft Tissue Neoplasms
Dogs
Kidney
copper pyruvaldehyde bis(N(4)-methylthiosemicarbazone) complex
Radiopharmaceuticals
Tumor Burden
Injections

ASJC Scopus subject areas

  • Cancer Research
  • Molecular Medicine
  • Radiology Nuclear Medicine and imaging

Cite this

Evaluation of Cu-PTSM as a tracer of tumor perfusion : Comparison with labeled microspheres in spontaneous canine neoplasms. / Mathias, Carla J.; Green, Mark; Morrison, Wallace B.; Knapp, Deborah W.

In: Nuclear Medicine and Biology, Vol. 21, No. 1, 1994, p. 83-87.

Research output: Contribution to journalArticle

@article{09cef4ee69db4a9f94cfb9d123ff4e61,
title = "Evaluation of Cu-PTSM as a tracer of tumor perfusion: Comparison with labeled microspheres in spontaneous canine neoplasms",
abstract = "Copper-62-labeled Cu-PTSM is a promising generator-produced PET tracer for myocardial, cerebral and renal perfusion. To evaluate whether [62Cu]Cu-PTSM could also serve as a blood flow tracer in PET studies of tumor tissue, the tumor uptake of [67Cu]Cu-PTSM was examined in dogs with spontaneously-occurring soft-tissue neoplasms. Copper-67-labeled Cu-PTSM was administered intravenously to four anesthetized dogs, followed c. 5 min later by a left ventricular injection of 85Sr-labeled microspheres (15 μm) to provide an independent measure of tumor perfusion. Forty-seven tumors (average weight = 2.5 ± 3.7 g) were obtained and sectioned into 80 samples. The correlation of 67Cu-PTSM uptake with regional renal perfusion was also examined in data from 395 tissue samples ranging in flow from 0.02 to 9.39 mL min-1 g-1. Rates of tumor perfusion assessed with 85Sr-labeled microspheres ranged from 0.011 to 3.0 mL min-1 g-1. No correlation was found between tumor size and the rate of tumor perfusion. However, an excellent linear correlation exists between tumor perfusion calculated from [67Cu]Cu-PTSM data and tumor perfusion measured with 85Sr-microspheres (r = 0.94 for 80 samples), suggesting that [62Cu]Cu-PTSM may be useful as a radiopharmaceutical for PET studies of tumor perfusion.",
author = "Mathias, {Carla J.} and Mark Green and Morrison, {Wallace B.} and Knapp, {Deborah W.}",
year = "1994",
doi = "10.1016/0969-8051(94)90133-3",
language = "English (US)",
volume = "21",
pages = "83--87",
journal = "Nuclear Medicine and Biology",
issn = "0969-8051",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Evaluation of Cu-PTSM as a tracer of tumor perfusion

T2 - Comparison with labeled microspheres in spontaneous canine neoplasms

AU - Mathias, Carla J.

AU - Green, Mark

AU - Morrison, Wallace B.

AU - Knapp, Deborah W.

PY - 1994

Y1 - 1994

N2 - Copper-62-labeled Cu-PTSM is a promising generator-produced PET tracer for myocardial, cerebral and renal perfusion. To evaluate whether [62Cu]Cu-PTSM could also serve as a blood flow tracer in PET studies of tumor tissue, the tumor uptake of [67Cu]Cu-PTSM was examined in dogs with spontaneously-occurring soft-tissue neoplasms. Copper-67-labeled Cu-PTSM was administered intravenously to four anesthetized dogs, followed c. 5 min later by a left ventricular injection of 85Sr-labeled microspheres (15 μm) to provide an independent measure of tumor perfusion. Forty-seven tumors (average weight = 2.5 ± 3.7 g) were obtained and sectioned into 80 samples. The correlation of 67Cu-PTSM uptake with regional renal perfusion was also examined in data from 395 tissue samples ranging in flow from 0.02 to 9.39 mL min-1 g-1. Rates of tumor perfusion assessed with 85Sr-labeled microspheres ranged from 0.011 to 3.0 mL min-1 g-1. No correlation was found between tumor size and the rate of tumor perfusion. However, an excellent linear correlation exists between tumor perfusion calculated from [67Cu]Cu-PTSM data and tumor perfusion measured with 85Sr-microspheres (r = 0.94 for 80 samples), suggesting that [62Cu]Cu-PTSM may be useful as a radiopharmaceutical for PET studies of tumor perfusion.

AB - Copper-62-labeled Cu-PTSM is a promising generator-produced PET tracer for myocardial, cerebral and renal perfusion. To evaluate whether [62Cu]Cu-PTSM could also serve as a blood flow tracer in PET studies of tumor tissue, the tumor uptake of [67Cu]Cu-PTSM was examined in dogs with spontaneously-occurring soft-tissue neoplasms. Copper-67-labeled Cu-PTSM was administered intravenously to four anesthetized dogs, followed c. 5 min later by a left ventricular injection of 85Sr-labeled microspheres (15 μm) to provide an independent measure of tumor perfusion. Forty-seven tumors (average weight = 2.5 ± 3.7 g) were obtained and sectioned into 80 samples. The correlation of 67Cu-PTSM uptake with regional renal perfusion was also examined in data from 395 tissue samples ranging in flow from 0.02 to 9.39 mL min-1 g-1. Rates of tumor perfusion assessed with 85Sr-labeled microspheres ranged from 0.011 to 3.0 mL min-1 g-1. No correlation was found between tumor size and the rate of tumor perfusion. However, an excellent linear correlation exists between tumor perfusion calculated from [67Cu]Cu-PTSM data and tumor perfusion measured with 85Sr-microspheres (r = 0.94 for 80 samples), suggesting that [62Cu]Cu-PTSM may be useful as a radiopharmaceutical for PET studies of tumor perfusion.

UR - http://www.scopus.com/inward/record.url?scp=0028085164&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028085164&partnerID=8YFLogxK

U2 - 10.1016/0969-8051(94)90133-3

DO - 10.1016/0969-8051(94)90133-3

M3 - Article

C2 - 9234268

AN - SCOPUS:0028085164

VL - 21

SP - 83

EP - 87

JO - Nuclear Medicine and Biology

JF - Nuclear Medicine and Biology

SN - 0969-8051

IS - 1

ER -